Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
EWTX
#1558
Edgewise Therapeutics, Inc. Common Stock
33.160
0
USD
-2.01%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-2.01%
Aylık Değişim
+11.39%
6 aylık değişim
+117.73%
Yıllık Değişim
+117.73%
Önceki Kapanış
33.840
0
Open
33.160
0
Bid
Ask
Low
33.160
0
High
33.160
0
Hacim
79
Piyasalar
ABD Borsası
Sağlık Hizmetleri
EWTX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
49.51 M
63.26 M
93.11 M
95.21 M
107.27 M
—
Valuation ratios
Enterprise value
740.98 M
534.08 M
938.12 M
2.5 B
2.6 B
7.87 B
Price to earnings ratio
-13.4
-6.98
-7.01
-18.41
-15.22
-48.14
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-17.11
-8.95
-7.62
-22.63
-17.76
-57.56
Price to book ratio
2.09
1.36
2.2
5.37
4.89
7.42
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.18
-0.29
-0.27
-0.3
-0.31
Return on equity %
-0.16
-0.2
-0.31
-0.29
-0.32
-0.33
Return on invested capital %
-65.99
-96.33
-158.55
-187.92
-168.3
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
26.97
21.53
19.5
19.93
19.85
96.22
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.89
-0.98
-1.44
-1.18
-1.4
-1.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.41
0.41
1.35
0.45
0.59
1.97
Net current asset value per share
7.56
6.66
5.13
5.15
5.28
21.13
Tangible book value per share
7.31
6.47
5
4.97
5.07
20.5
Working capital per share
7.28
6.35
4.87
4.89
5.01
20.23
Book value per share
7.31
6.47
5
4.97
5.07
20.5
Haberler
Edgewise Therapeutics hissesi 34,03 dolarda zirve yaptı
Edgewise Therapeutics hissesi 33,5 dolarda zirve yaptı
Edgewise Therapeutics CMO 685 bin dolarlık hisse sattı
Edgewise Therapeutics hissesi 31,86 dolarla zirve yaptı
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
JPMorgan raises Edgewise Therapeutics price target on pipeline outlook
Raymond James, deneme verileri sonrası Edgewise hissesinde Al tavsiyesi verdi
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock after trial data
Truist, deneme verileri sonrası Edgewise hissesi için görüşünü korudu
Truist reiterates Edgewise Therapeutics stock rating on trial data
Edgewise, Becker distrofisi denemesinde fonksiyonel istikrar bildirdi
Edgewise reports functional stability in Becker dystrophy trial